Arch Resources reported mixed Q4 financial results, with revenue beating estimates and EPS missing it. The company expects a step-up in coking coal production as well as another first-quartile cost performance in 2024.
R&D HighlightsAlnylam announces today updates to the statistical analysis plan for the HELIOS-B Phase 3 study of vutrisiran in patients with ATTR amyloidosis with cardiomyopathy. These will include updates to the
Genuine Parts sees stock decline despite beating earnings estimates, as revenue misses. The company also introduced a global restructuring designed to better align its assets and further improve the efficiency of the business.
Southern Co. Q4 fiscal 2023 operating revenue down 14.2% to $6.04B, due to lower fuel costs. Adjusted EPS beats at $0.64. 2024 outlook: $3.95-$4.05 per share.